Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Mata

Showing results (61-70 of 144) with videos related to

Pageof 15
Sort By:
Nutrients|January 10, 2026
Lipoprotein-Specific Fatty Acid Profiles in Familial Hypercholesterolemia: Associations with Cardiovascular History and Dietary PatternsAnallely López-Yerena, Raquel Arroyo-Olivares, Victoria Santisteban, et al.
Brain and Language|May 4, 2004
Can small lesions induce language reorganization as large lesions do?Fernando Maestú, Cristobal Saldaña, Carlos Amo, et al.
Journal of Clinical Lipidology|August 12, 2014
rs1801275 Interleukin-4 receptor alpha polymorphism in familial hypercholesterolemiaJuan F Sánchez Muñoz-Torrero, Maria D Rivas, Jose Zamorano, et al.
Atherosclerosis|March 31, 2012
Detection of subclinical atherosclerosis in familial hypercholesterolemia using non-invasive imaging modalitiesPaloma Caballero, Rodrigo Alonso, Paloma Rosado, et al.
The American Journal of Clinical Nutrition|February 28, 2002
Fatty acid saturation of the diet and plasma lipid concentrations, lipoprotein particle concentrations, and cholesterol efflux capacityMaria Teresa Montoya, Amelia Porres, Sagrario Serrano, et al.
International Journal of Molecular Sciences|June 2, 2021
Alternative C3 Complement System: Lipids and AtherosclerosisMaisa Garcia-Arguinzonis, Elisa Diaz-Riera, Esther Peña, et al.
Cardiovascular Research|February 16, 2020
High miR-133a levels in the circulation anticipates presentation of clinical events in familial hypercholesterolaemia patientsRafael Escate, Teresa Padró, Rosa Suades, et al.
Medicine|August 28, 2020
Loss-of-function mutation of PCSK9 as a protective factor in the clinical expression of familial hypercholesterolemia: A case reportAne Bayona, Francisco Arrieta, Carmen Rodríguez-Jiménez, et al.
American Heart Journal|September 25, 2004
Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatinEvan Stein, Steen Stender, Pedro Mata, et al.
The American Journal of Cardiology|November 9, 2002
Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemiaClaude Gagné, Harold E Bays, Stuart R Weiss, et al.
Pageof 15

Showing results (61-70 of 144) with videos related to

Sort By:
Pageof 15
Nutrients|January 10, 2026
Lipoprotein-Specific Fatty Acid Profiles in Familial Hypercholesterolemia: Associations with Cardiovascular History and Dietary PatternsAnallely López-Yerena, Raquel Arroyo-Olivares, Victoria Santisteban, et al.
Brain and Language|May 4, 2004
Can small lesions induce language reorganization as large lesions do?Fernando Maestú, Cristobal Saldaña, Carlos Amo, et al.
Journal of Clinical Lipidology|August 12, 2014
rs1801275 Interleukin-4 receptor alpha polymorphism in familial hypercholesterolemiaJuan F Sánchez Muñoz-Torrero, Maria D Rivas, Jose Zamorano, et al.
Atherosclerosis|March 31, 2012
Detection of subclinical atherosclerosis in familial hypercholesterolemia using non-invasive imaging modalitiesPaloma Caballero, Rodrigo Alonso, Paloma Rosado, et al.
The American Journal of Clinical Nutrition|February 28, 2002
Fatty acid saturation of the diet and plasma lipid concentrations, lipoprotein particle concentrations, and cholesterol efflux capacityMaria Teresa Montoya, Amelia Porres, Sagrario Serrano, et al.
International Journal of Molecular Sciences|June 2, 2021
Alternative C3 Complement System: Lipids and AtherosclerosisMaisa Garcia-Arguinzonis, Elisa Diaz-Riera, Esther Peña, et al.
Cardiovascular Research|February 16, 2020
High miR-133a levels in the circulation anticipates presentation of clinical events in familial hypercholesterolaemia patientsRafael Escate, Teresa Padró, Rosa Suades, et al.
Medicine|August 28, 2020
Loss-of-function mutation of PCSK9 as a protective factor in the clinical expression of familial hypercholesterolemia: A case reportAne Bayona, Francisco Arrieta, Carmen Rodríguez-Jiménez, et al.
American Heart Journal|September 25, 2004
Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatinEvan Stein, Steen Stender, Pedro Mata, et al.
The American Journal of Cardiology|November 9, 2002
Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemiaClaude Gagné, Harold E Bays, Stuart R Weiss, et al.
Pageof 15